How to safely switch antidepressants
without losing ground

Your antidepressant isn't working. Or it's working for the depression but the side effects are unbearable. Or it worked for a while and now it doesn't. Whatever the reason, your provider has suggested switching to a different medication.

This is one of the most common scenarios in psychiatry, and it's also one of the most anxiety-producing for patients. Will the new one work? What happens during the transition? Will the depression come roaring back? Will there be withdrawal symptoms?

These are legitimate concerns. But switching antidepressants is a well-established process with clear strategies to minimize risk. Here's what you need to know.

When Is It Time to Switch?

Guidelines recommend giving an antidepressant an adequate trial before deciding it hasn't worked. The VA/DoD clinical practice guideline defines an adequate trial as 6 to 12 weeks at a maximized dose (either the FDA maximum or the maximum the patient can tolerate). The STAR*D trial found that patients commonly required 8 weeks or more to achieve response or remission.

However, if there's been no improvement at all after 4 to 6 weeks at a therapeutic dose, or if side effects are intolerable at any point, switching is reasonable. There's no benefit to suffering through months of a medication that clearly isn't helping.

Before switching, a good provider will first confirm the diagnosis is correct (conditions like bipolar disorder, thyroid disease, and substance use can mimic depression), verify that the medication was taken consistently, ensure the dose was truly adequate, and assess whether adding psychotherapy might be a better next step than switching medications.

The Three Switching Strategies

There are three main approaches to switching antidepressants, and the right one depends on what you're switching from and to.

The first is the cross-taper (also called a concurrent or overlapping switch). This is the most commonly used strategy. The current medication is gradually reduced while the new medication is gradually introduced, with a period of overlap where both are being taken simultaneously. The advantage is that you're never completely unmedicated, which reduces the risk of depressive relapse. The disadvantage is a temporary period of taking two medications, which can increase side effects and, in rare cases, the risk of drug interactions.

The second is the sequential switch (stop, then start). The current medication is tapered and fully discontinued before the new medication is started. This is the "cleanest" approach because there's no overlap between medications, eliminating the risk of drug interactions. The disadvantage is a gap period where you're on no antidepressant, which can feel uncomfortable and carries a risk of symptom worsening. This strategy is preferred when the first medication produced no benefit at all, since there's nothing to lose by discontinuing it completely.

The third is the direct switch. The current medication is stopped and the new one is started the next day, without a taper. This is sometimes appropriate when switching between medications in the same class (for example, from one SSRI to another) at low doses, but it's generally not recommended for higher doses or when switching between different classes.

The One Situation That Requires a Washout Period

If you are switching to or from a monoamine oxidase inhibitor (MAOI), such as phenelzine (Nardil) or tranylcypromine (Parnate), a mandatory washout period is required. This means completely stopping the first medication and waiting a defined period before starting the MAOI (or vice versa). For most antidepressants, this washout is at least 2 weeks. For fluoxetine (Prozac), which has an exceptionally long half-life, the washout period is at least 5 weeks.

This is not optional. Combining an MAOI with an SSRI, SNRI, or certain other serotonergic medications can cause serotonin syndrome, a potentially life-threatening condition characterized by agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle twitching, and in severe cases, seizures and death. Most cases of serotonin syndrome involve the combination of two serotonergic drugs, and the most dangerous combination is an MAOI with an SSRI or SNRI.

MAOIs are rarely prescribed today, but if you're on one or being switched to one, this washout period is critical.

What About Serotonin Syndrome When Switching Between SSRIs?

Switching between two SSRIs, or from an SSRI to an SNRI, carries a much lower risk of serotonin syndrome than combinations involving MAOIs. A cross-taper between these medications is generally safe when done gradually. However, the risk is not zero, particularly if the doses overlap at high levels or if other serotonergic medications (like tramadol, triptans, or certain supplements like St. John's Wort) are also being taken.

Signs to watch for during any antidepressant switch include agitation or restlessness, muscle twitching or tremor, rapid heartbeat, diarrhea, and confusion. If these symptoms cluster together after a medication change, contact your provider immediately.

Discontinuation Symptoms: Real but Manageable

When you reduce or stop an antidepressant, you may experience discontinuation symptoms. These are not a sign of addiction. They reflect your brain adjusting to a change in serotonin (or norepinephrine) levels.

Common discontinuation symptoms can be remembered with the mnemonic FINISH: flu-like symptoms, insomnia, nausea, imbalance (dizziness), sensory disturbances (brain zaps, tingling), and hyperarousal (anxiety, irritability). These typically appear within 2 to 4 days of dose reduction and can last for several weeks, though they are usually mild and self-limited with a proper taper.

The risk of discontinuation symptoms varies by medication. Medications with shorter half-lives are more likely to cause withdrawal effects. Paroxetine (Paxil) and venlafaxine (Effexor) are the most commonly associated with discontinuation symptoms. Fluoxetine (Prozac), with its very long half-life, rarely causes significant withdrawal.

The key to minimizing discontinuation symptoms is a slow, gradual taper. A dose reduction of approximately 25% every 4 weeks is a reasonable strategy. A faster taper of 12.5% every 2 weeks is also used. Research shows that a gradual taper can reduce the incidence of discontinuation symptoms to as low as 5%, compared to 78% with abrupt discontinuation.

Short tapers of 2 to 4 weeks have been shown to have minimal benefit over abrupt discontinuation. For people who have been on an antidepressant for months to years, a longer taper (sometimes several months) may be needed.

Does Switching to a Different Class Work Better?

This is a common assumption: if an SSRI didn't work, switching to a "different type" of antidepressant should be more effective. The evidence doesn't support this.

A JAMA review found that available evidence does not indicate that changing to an antidepressant of a different type or class has a greater likelihood of success than changing to a similar medication. The STAR*D trial found similar remission rates whether patients switched to bupropion, sertraline, or venlafaxine, despite these being three different classes.

This means the choice of what to switch to should be guided by side effect profile, the patient's specific symptoms, and practical considerations like cost and drug interactions, rather than by the assumption that a different mechanism of action will automatically work better.

What to Expect During the Transition

The transition period is real, and it helps to know what's normal.

During the first 1 to 2 weeks, you may experience some discontinuation symptoms from the old medication and some startup side effects from the new one (nausea, headache, insomnia, or increased anxiety are common). This overlap of symptoms can feel worse than either medication alone, but it's temporary.

By weeks 2 to 4, the startup side effects of the new medication typically begin to subside. You may start to notice early signs of benefit, though full response often takes 6 to 8 weeks.

By weeks 6 to 12, you should have a clearer picture of whether the new medication is working. If there's been no improvement by 8 weeks at an adequate dose, it's time to reassess.

During this entire period, stay in close contact with your provider. Report any new or worsening symptoms, particularly increased suicidal thoughts, severe anxiety, or signs of serotonin syndrome.

The Bottom Line

Switching antidepressants is not starting over. It's a standard, well-understood part of depression treatment. The STAR*D trial showed that among patients who didn't respond to their first antidepressant, about one-quarter to one-third responded to the next one. And among those who persisted through multiple steps, the majority eventually found something that worked.

The process requires patience, communication with your provider, and a willingness to tolerate some temporary discomfort during the transition. But the goal, finding a medication that treats your depression without creating problems you can't live with, is absolutely achievable.

Don't let fear of the switch keep you stuck on a medication that isn't working. The transition is temporary. The benefit of finding the right medication is not.